Outline

“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector

Authors

Amir Farshchi, Abbas Kebriaeezadeh,*, Rassoul Dinarvand
*Corresponding Author: Abbas Kebriaeezadeh is currently working as Professor of Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Science, Tehran, Iran. He could be reached at the following e-mail address: kebriaee@tums.ac.ir Email:

Iranian Journal of Pharmaceutical Research:Vol. 14, issue 1; 1-2
Published online:Jan 31, 2015
Article type:Editorial_imported
How to Cite:Farshchi A, Kebriaeezadeh A, Dinarvand R. “Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector. Iran J Pharm Res. 2015;14(1):e125295. doi: https://doi.org/10.22037/ijpr.2015.1667

Information plays a vital role in effective management of any system. With the Health Management Information System (HMIS), specific information may be provided to support the decision makers at various levels of the health system to assist evidence-based decision making. It is almost three decades (from 1984) that Iranian Ministry of Health (MoH) has used HMIS in its pharmaceutical sector as a mean to have an efficient regulation. Pharmaceutical distributor companies have reported their sales data to MoH at monthly intervals. Each company should report its data by 5th of each month. “Iranian MoH Annual Pharma Statistics” or “Amarnameh daruee Iran” will be published as software after combining this data with other related data and statistical analysis. This database is a basis for deciding issues of many policy makers, and management possesses in pharmaceutical sector. After an efficient coordination between MoH and distributors, each company reports its data in a defined format including some detailed information. Table 1 shows a sample chart of characteristics for this HMIS. Each pharmaceutical product in each city/each month has one record. For each product with brand name, the specific code will be used. If there is not any code for branded products, it is very important to get feedback to MoH to solve such problems. Figure 1 is a sample file format of a hypothetical company named XY to show more details. Until 1998 this information was reported as a manual printed database. From 1998 to 2003 it was reported as a book, and since 2003 the electronic database including data since 1998 has been published.
Table 1
Characteristics of MOH Annual Pharma Statistics variables
VariableNumber of each variable characterDefinition of each characterNumber of lines for each variable
Operation codeOne digitThis code is for determining that each data in its line is for witch condition?For example: Sales (Code 1), Stock (Code 2), Rejects from sales (Code 3)1
Two letter code for each companyTwo digitsThis code is special for each company2-3
Drug codeFive digits-4-8
City codeFive digits-9-13
Sales (Number of boxes) in each monthEight digits-14-21
Packaging (number of units in each box) Four digits-22-25
Consumer price (Rial)Eight digitsFor each box26-33
Three letter code for producer companyThree digitsThis code is for producer or importer company34-36
Production or importation codeOne digits1: Production2: importation37
Serial number of recordSeven digitsFor each records from company38-44
DateFour digitsyymm45-48
Sample format of MOH Annual Pharma Statistics data.
Figure 1
Sample format of MOH Annual Pharma Statistics data.
The growing use of high-throughput technologies in health management and the complexity of data generated in such area have created a need for dedicated software systems in order to collect, store and manage the data. We know such HMISs play an important role in healthcare management; however, more efforts should be done to upgrade the system based on new demands. For example; special attention to benchmark from other countries and adopting this system for the pharmaceutical industry will improve this HMIS. Furthermore, such HMISs could be designed and implemented for providing updated and relevant information on the consumption, and rational drug use for policy makers. To justify this purpose, we must always endeavor to have a dynamic system to collect and evaluate the relevant information. “Annual Pharma Statistics” is a good example for implementing health information system in pharmaceutical sector in Iran.
Abbas Kebriaeezadeh is currently working as Professor of Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Science, Tehran, Iran. He could be reached at the following e-mail address: kebriaee@tums.ac.ir

Copyright

© 2015 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Similar Articles

31
Jan
2017

Trends in Iran Pharmaceutical Market

Abdol Majid Cheraghali

Cheraghali AM. Trends in Iran Pharmaceutical Market. Iran J Pharm Res. 2017;16(1):e124945. doi: https://doi.org/10.22037/ijpr.2017.2165

31
Oct
2018
A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran

A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran

Hossein Safari,
Mohammad Arab,
Arash Rashidian,
Abbas Kebriaee-Zadeh,
Hasan Abolghasem Gorji

Safari H, Arab M, Rashidian A, Kebriaee-Zadeh A, Abolghasem Gorji H. A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran. Iran J Pharm Res. 2018;17(4):e124857. doi: https://doi.org/10.22037/ijpr.2018.2307

31
Jan
2019
The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets

The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets

Hosein Shabaninejad,
Hasan Yusefzadeh,
Gholamhossein Mehralian,
Bahlol Rahimi

Shabaninejad H, Yusefzadeh H, Mehralian G, Rahimi B. The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets. Iran J Pharm Res. 2019;18(1):e126116. doi: https://doi.org/10.22037/ijpr.2019.2355

14
Feb
2026
Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran

Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran

Mohammadamir Nemati,
Behzad Fatemi,
Fatemeh Soleymani,
Meysam Seyedifar,
Donya Zali,
Zahra Shahali
,et al.

Nemati M, Fatemi B, Soleymani F, Seyedifar M, Zali D, et al. Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran. Iran J Pharm Res. 2026;25(1):e158927. doi: https://doi.org/10.5812/ijpr-158927

13
Feb
2013
Assessment of Pharmacy Information System Performance in Selected Hospitals in Isfahan City During 2011

Assessment of Pharmacy Information System Performance in Selected Hospitals in Isfahan City During 2011

Sakineh Saqaeian Nejad Isfahani,
Razieh Mirzaeian,
Mahbobe Habibi

Saqaeian Nejad Isfahani S, Mirzaeian R, Habibi M. Assessment of Pharmacy Information System Performance in Selected Hospitals in Isfahan City During 2011. Jundishapur J Nat Pharm Prod. 2013;8(1):3-9. doi: https://doi.org/10.17795/jjnpp-5440

More by these authors

Amir FarshchiPubMedScholar
Abbas KebriaeezadehPubMedScholar
Rassoul DinarvandPubMedScholar
Share
Cited by
Metrics